All News Crossject

Equities

Market Closed - Euronext Paris Other stock markets 11:20:14 2024-05-31 am EDT			5-day change	1st Jan Change
2.31 ^EUR	-2.74%		+16.31%	-53.52%

May. 27	Crossject: capital increase until May 30	CF
May. 03	Crossject: praised for extended agreement on Zepizure	CF

Crossject announces publication of clinical data on ZEPIZURE ® in Neurology and Therapy	May. 30	GL
Crossject: capital increase until May 30	May. 27	CF
Crossject: praised for extended agreement on Zepizure	May. 03	CF
Crossject signs a geographic extension of ZEPIZURE® commercialization agreement in Europe	May. 02	GL
Crossject Signs A Geographic Extension of ZEPIZURE Commercialization Agreement in Europe	May. 02	CI
CROSSJECT : We welcome the securing of the group’s financial needs	May. 02	AL
Crossject reports audited financial results for 2023	Apr. 25	GL
CROSSJECT : Patience is a virtue… hopefully	Apr. 03	AL
Crossject trading on Euronext to resume as usual on Wednesday April 3	Apr. 02	GL
Crossject advances in its U.S. Strategy and reports Financial Results for 2023	Apr. 02	GL
Crossject Société Anonyme Reports Earnings Results for the Full Year Ended December 31, 2023	Apr. 02	CI
Crossject gender equality score reaches 96/100 in 2024	Mar. 08	GL
Crossject gender equality score reaches 96/100 in 2024	Mar. 08	AQ
CROSSJECT : Invest Securities slightly reduces its target	Feb. 28	CF
CROSSJECT : Securing the financing needs	Feb. 28	AL
Crossject: share price falls after convertible bond issue	Feb. 27	CF
Crossject obtains a financing up to €12 million, in two tranches	Feb. 27	GL
Crossject obtains a financing up to €12 million, in two tranches	Feb. 27	AQ
Crossject Société Anonyme announced that it expects to receive ?12 million in funding	Feb. 25	CI
CROSSJECT : No news is not always good news...	Feb. 08	AL

No results for this search